Screener
Cytokinetics CYTK Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Cytokinetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338217
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts receivable, net | 24,432 | 17,764 |
| Inventories | 380 | — |
| Prepaid expenses and other current assets | 17,989 | 16,990 |
| Total current assets | 1,208,487 | 916,975 |
| Long-term investments | 538,317 | 335,048 |
| Property and equipment, net | 78,916 | 79,194 |
| Operating lease right-of-use assets | 72,896 | 75,979 |
| Inventories, long-term | 6,529 | — |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Cytokinetics's total current assets?
- Cytokinetics (CYTK) reported total current assets of $1.21B in Q2 2026.
- How has Cytokinetics's total current assets changed year-over-year?
- Cytokinetics's total current assets increased by 36.3% year-over-year, from $886.54M to $1.21B.
- What is the long-term trend for Cytokinetics's total current assets?
- Over 5 years (2020 to 2025), Cytokinetics's total current assets has grown at a 14.1% compound annual growth rate (CAGR), from $474.22M to $916.98M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Cytokinetics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude